1. Home
  2. NXPLW vs PII Comparison

NXPLW vs PII Comparison

Compare NXPLW & PII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPLW
  • PII
  • Stock Information
  • Founded
  • NXPLW N/A
  • PII 1954
  • Country
  • NXPLW United States
  • PII United States
  • Employees
  • NXPLW 166
  • PII N/A
  • Industry
  • NXPLW Telecommunications Equipment
  • PII Recreational Games/Products/Toys
  • Sector
  • NXPLW Telecommunications
  • PII Consumer Discretionary
  • Exchange
  • NXPLW Nasdaq
  • PII Nasdaq
  • Market Cap
  • NXPLW N/A
  • PII N/A
  • IPO Year
  • NXPLW N/A
  • PII 1987
  • Fundamental
  • Price
  • NXPLW N/A
  • PII $33.18
  • Analyst Decision
  • NXPLW
  • PII Hold
  • Analyst Count
  • NXPLW 0
  • PII 13
  • Target Price
  • NXPLW N/A
  • PII $51.45
  • AVG Volume (30 Days)
  • NXPLW 6.4K
  • PII 1.9M
  • Earning Date
  • NXPLW 03-31-2025
  • PII 04-29-2025
  • Dividend Yield
  • NXPLW N/A
  • PII 8.10%
  • EPS Growth
  • NXPLW N/A
  • PII N/A
  • EPS
  • NXPLW N/A
  • PII 1.95
  • Revenue
  • NXPLW $66,482,000.00
  • PII $7,273,000,000.00
  • Revenue This Year
  • NXPLW N/A
  • PII N/A
  • Revenue Next Year
  • NXPLW N/A
  • PII $4.66
  • P/E Ratio
  • NXPLW N/A
  • PII $17.02
  • Revenue Growth
  • NXPLW 179.89
  • PII N/A
  • 52 Week Low
  • NXPLW $0.25
  • PII $30.92
  • 52 Week High
  • NXPLW $0.26
  • PII $90.62
  • Technical
  • Relative Strength Index (RSI)
  • NXPLW N/A
  • PII 36.87
  • Support Level
  • NXPLW N/A
  • PII $32.14
  • Resistance Level
  • NXPLW N/A
  • PII $35.02
  • Average True Range (ATR)
  • NXPLW 0.00
  • PII 2.81
  • MACD
  • NXPLW 0.00
  • PII -0.31
  • Stochastic Oscillator
  • NXPLW 0.00
  • PII 18.80

About NXPLW NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

Share on Social Networks: